KH Group’s financial reporting and Annual General Meeting in 2027 Sep 23, 2026 04:50AM

KH Group Plc Stock Exchange Release 23 Septemberr 2026 at 11:50 am EEST  KH Group’s financial reporting and Annual General Meeting in 2027KH Group Plc will publish financial reports in 2027 as follows: 

  • Financial Statements Release for 2026 on Friday,12 February 2027
  • Annual Report for 2026 on week 12
  • Interim Report for January-March 2027 on Tuesday, 4 May 2027
  • Half-Year Report for January-June 2027 on Thursday, 12 August 2027
  • Interim Report for... (continue reading...)

Melco’s Morpheus becomes Macau’s first hotel to receive Three MICHELIN Keys Sep 23, 2026 04:31AM

MACAU, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Melco Resorts & Entertainment (NASDAQ: MLCO) announces that Morpheus at City of Dreams has been awarded Three MICHELIN Keys in the MICHELIN Guide’s 2026 global hotel selection, becoming the first hotel in Macau to receive the distinction. Morpheus was promoted from Two Keys, which it held in the 2025 selection.

Three MICHELIN Keys, described by the Guide as "an extraordinary stay", is the highest level of recognition in the... (continue reading...)


BUYBACK OF RIKSBANK CERTIFICATES Sep 23, 2026 04:15AM CERTIFICATE MATURITY260930FIXED RATE (STEERING RATE + 10 b.p.)       1.85 %VOLUME BOUGHT40.00 BLNTRADE DAY260923SETTLEMENT DAY260924  
DSV - Q3 2026 ANALYST CONFERENCE CALL Sep 23, 2026 04:11AM

We expect to release the Q3 2026 interim results of DSV A/S in the morning of 21 October 2026. A webcast and conference call will be held at 11:00 am CEST.      

At the conference call, Jens H. Lund, Group CEO, and Michael Ebbe, Group CFO, will present the Q3 2026 Interim Financial Report. The presentation will be followed by a Q&A session.

Date:                 21 October 2026Time:                 11:00 am CEST

To attend the webcast presentation, please go to ... (continue reading...)


Scarlet Therapeutics Secures DARPA Agreement to Develop Adaptive Smart Red Blood Cells Sep 23, 2026 04:00AM

Agreement, worth up to $14 million, validates the potential of pioneering red blood cell technology platform

BRISTOL, United Kingdom, Sept. 23, 2026 (GLOBE NEWSWIRE) -- Scarlet Therapeutics Ltd (‘Scarlet’), a biotech company developing red blood cell-based therapeutics, today announced that it has entered into an agreement with the Defense Advanced Research Projects Agency (DARPA) to advance the development of smart red blood cells (SRBCs). Scarlet will lead a... (continue reading...)


More Globe Newswire

View Older Stories

Sep 23, 2026 04:00AM Boehringer Ingelheim and AWARE launch new Stop Rabies project in Zimbabwe to help protect dogs and communities
Sep 23, 2026 04:00AM Actimed Therapeutics Completes Recruitment for PROACT Phase 2a Study Evaluating S-pindolol benzoate (ACM 001.1) in Obese Adults During and After Semaglutide Therapy
Sep 23, 2026 04:00AM Engitix appoints Sonia Quaratino, MD, PhD as EVP Chief Medical Officer as its ECM pipeline moves toward clinical development
Sep 23, 2026 03:03AM Bitwise launches first Crypto ETP tracking Lighter, a fast-growing challenger to Hyperliquid
Sep 23, 2026 03:00AM Anaconda Biomed Secures $56 Million Financing from New and Existing Investors
Sep 23, 2026 03:00AM XM Expands Unlimited Cashback Promo Across All Assets and Copy Trading
Sep 23, 2026 03:00AM Albatross and OfferUp Partner on Long-term Engagement After Real-Time AI Discovery Feed Pilot Lifts Engagement 84%
Sep 23, 2026 03:00AM iFAST Global Bank Enhances Its Financial Tools with ‘Get Paid’ Features for Faster and Simpler Business Payments
Sep 23, 2026 02:52AM Toobit Launches Exclusively VIP R4 Event With 250,000 USDT in Rewards
Sep 23, 2026 02:38AM Trevor Noah, Esther Perel, and Dame Jacinda Ardern to headline Nordic Business Forum 2027 in Helsinki
Sep 23, 2026 02:30AM Space42 and Telespazio Ibérica Begin Wildfire Monitoring in Spain supported by High Altitude Platform Systems
Sep 23, 2026 02:30AM ALSTOM S.A: Alstom signs launch order with Northrail for its new Traxx Shunter Platform
Sep 23, 2026 02:30AM Exor Press Release - Buyback Launch
Sep 23, 2026 02:27AM Siltrax C2 Series Redefines Air-Cooled Fuel Cell Power for UAV and Off-Grid Applications
Sep 23, 2026 02:16AM Crédit Agricole Assurances has successfully priced 750 million euros of Tier 2 subordinated notes at a fixed annual interest rate of 5.125% under its EMTN programme
Sep 23, 2026 02:02AM NBPE Announces August Monthly NAV Update
Sep 23, 2026 02:01AM NBPE Announces Appointment of New Non-Executive Director and Chairman Designate
Sep 23, 2026 02:00AM Norsk Hydro: Invitation to Hydro's third quarter results 2026
Sep 23, 2026 02:00AM NBPE Announces Interim Results
Sep 23, 2026 02:00AM NBPE Announces Transaction in Own Shares
Sep 23, 2026 02:00AM Transaction in Own Shares
Sep 23, 2026 02:00AM City of Tallinn to sell its shareholding in Coop Pank
Sep 23, 2026 02:00AM Norsk Hydro: Invitation to Hydro's third quarter results 2026
Sep 23, 2026 01:54AM Poul Sejr Nielsen Service A/S and Poul Sejr Nielsen EL A/S join InstallatørGruppen
Sep 23, 2026 01:37AM Arcadis comments on WSP's decision to not proceed with its offer
Sep 23, 2026 01:34AM The Hemp Doctor's Cannabis Consumer Behavior Survey: Average Buyer Is 45
Sep 23, 2026 01:34AM The 2nd Annual Entertainment Finance Summit Returns to the FOX Studio Lot, Introducing Private-Capital platform focused on alternative Investment Opportunities in Film and Entertainment
Sep 23, 2026 01:34AM The Hemp Doctor's Cannabis Consumer Behavior Survey: Average Buyer Is 45
Sep 23, 2026 01:33AM A Full Moon for Every Child: STARTRADER's STARCARES Brings Support to SOS Children's Village Ho Chi Minh City
Sep 23, 2026 01:33AM A Full Moon for Every Child: STARTRADER's STARCARES Brings Support to SOS Children's Village Ho Chi Minh City
Sep 23, 2026 01:30AM OSE Immunotherapeutics Announces Presentation of Combi-TED Phase 2 Topline Results of Tedopi® in Non-Small Cell Lung Cancer at the ESMO 2026 Meeting
Sep 23, 2026 01:30AM OSE Immunotherapeutics Announces Presentation of Combi-TED Phase 2 Topline Results of Tedopi® in Non-Small Cell Lung Cancer at the ESMO 2026 Meeting
Sep 23, 2026 01:24AM Apeing Advances to Stage 5 of $APEING Token Presale as Community Participation Grows
Sep 23, 2026 01:15AM Positive interim data shows Roche’s sefaxersen significantly reduces proteinuria in people with IgA nephropathy (IgAN)
Sep 23, 2026 01:00AM Fairplay Educates Users on How to Identify Fake Login Pages and Avoid Online Scams
Sep 23, 2026 01:00AM Piano Academy Agenda Features Scott Woody and Max Schrems
Sep 23, 2026 01:00AM Press Release - First-half 2026 results: AFL Group reports solid results and achieves strategic milestones in the development of its refinancing tools
Sep 23, 2026 01:00AM Start of Day Message
Sep 23, 2026 01:00AM Change in Roche’s Board of Directors
Sep 23, 2026 12:34AM Osisko Gold Announces Pricing of Upsized US$600 Million 9.250% Senior Secured Notes Offering to Refinance Appian Project Financing Facility and Advance Cariboo Gold Project
Sep 23, 2026 12:19AM Airwheel Wins European Product Design Award for AI Wheel Cabin 20 Inch Luxury Smart Scooter Carry on Hand Boarding Travel Electric Suitcase
Sep 22, 2026 11:35PM Angi Appoints Michael Steib As CEO
Sep 22, 2026 11:22PM Chery Group Tops UK August Sales, with OMODA & JAECOO Contributing 3 Models in Top-10
Sep 22, 2026 11:22PM Chery Group Tops UK August Sales, with OMODA & JAECOO Contributing 3 Models in Top-10
Sep 22, 2026 11:00PM Maygrove AI Growbot Brings a Smarter, Easier Way to Grow Fresh Plants at Home
Sep 22, 2026 10:33PM MalaSwap Launches on Arc Following Mainnet Debut, Bringing $MALA-Powered Trading and AI Tools Online
Sep 22, 2026 10:27PM Computer Modelling Group Ltd. Announces Preliminary Results of Substantial Issuer Bid
Sep 22, 2026 10:00PM Li Bang International Corporation Inc. Announces Results of September 2026 Extraordinary General Meeting
Sep 22, 2026 09:15PM Crypto News Today: Bitcoin ETFs Attract $998.95M as Apeing Enters Stage 5 of New Crypto Presale After Raising $102K+
Sep 22, 2026 09:15PM New Crypto: AlphaPepe Presale Nears 12,000 Holders as Ethereum Price Prediction Points to $8,000
View Older Stories